Publications by authors named "James M Faed"

Claim this Profile
W
Warfarin reversal in patients with antiphospholipid syndrome: Caution required, but clear guidance not available.
Krishna G Badami, James M Faed

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Platelet Lysate Compared to Autologous and Allogeneic Serum Eye Drops.
Jie Zhang, Daryl Crimmins, James M Faed, Peter Flanagan, Charles N J McGhee

Transl Vis Sci Technol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous intracerebral haemorrhage: a rare complication of aortic aneurysm endoleak.
Neal Kerr, Jasmin Kerr, James M Faed, Jo Krysa

BMJ Case Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of a Factor Xa-Based Clotting Time Test for Enoxaparin: A Proof-of-Concept Study.
Deborah P J Ng, Stephen B Duffull, James M Faed, Geoffrey K Isbister, Abhishek Gulati

Clin Appl Thromb Hemost· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
Morad-Rémy Muhsin-Sharafaldine, Bailey R Kennedy, Sarah C Saunderson, Catrin R Buchanan, Amy C Dunn, James M Faed

Biochim Biophys Acta Gen Subj· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Morad-Rémy Muhsin-Sharafaldine, Sarah C Saunderson, Amy C Dunn, James M Faed, Torsten Kleffmann

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for Enoxaparin.
Abhishek Gulati, James M Faed, Geoffrey K Isbister, Stephen B Duffull

Pharm Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel heterozygous Bbeta (c.1311T>A) mutation (Fibrinogen St Kilda) associated with recurrent pregnancy loss.
Ni Ni Aung, Hannah Kennedy, James M Faed, Stephen O Brennan

Pathology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octanoate in Human Albumin Preparations Is Detrimental to Mesenchymal Stromal Cell Culture.
Way-Wua Wong, Andrew D MacKenzie, Vicky J Nelson, James M Faed, Paul R Turner

Stem Cells Int· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia.
Stephen O Brennan, Hilda Mangos, James M Faed

Thromb Haemost· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran: rational dose individualisation and monitoring guidance is needed.
Stephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, Paul J Zufferey, James M Faed

N Z Med J· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin.
Abhishek Gulati, James M Faed, Geoffrey K Isbister, Stephen B Duffull

Pharm Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis